Skip to main content
William A. Fischer, II, MD | Institute for Global Health and Infectious Diseases

William A. Fischer, II, MD

Director of Emerging Pathogens, Institute for Global Health & Infectious Diseases

Co-Director, UNC Regional Special Pathogens Treatment Center

Co-director, UNC Project-Liberia

Co-Director, Viral Hemorrhagic Fever Research

Associate Professor of Medicine, Division of Pulmonary and Critical Care

William-Fischer-IGHID-Profile

Contact Information

Address

Office:
130 Mason Farm Rd
Suite 2111
Chapel Hill, NC 27599

Resources

William A. Fischer, II, MD

Director of Emerging Pathogens, Institute for Global Health & Infectious Diseases

Co-Director, UNC Regional Special Pathogens Treatment Center

Co-director, UNC Project-Liberia

Co-Director, Viral Hemorrhagic Fever Research

Associate Professor of Medicine, Division of Pulmonary and Critical Care

Areas of Interest

Emerging pathogens, severe viral infections, critical illness, outbreak response

About

Dr. Fischer is a pulmonary and critical care trained physician-scientist and an EPA full-time permanent faculty member of the UNC Division of Pulmonary and Critical Care Medicine with specific expertise in severe emerging viral pathogens including Ebola virus disease, Lassa fever, and SARS-CoV-2. He has hands-on experience in providing care to patients with Ebola virus disease and Lassa fever, is a member of the WHO Health Emergencies Clinical Team, served as a content-matter expert on call with the CDC Ebola Response Team, and has served as the lead consultant to the WHO for the last two Ebola outbreaks in the DRC and the most recent Ebola Sudan outbreak in Uganda. He is an experienced clinical researcher with expertise in designing and implementing clinical research studies, including therapeutic trials and observational studies. Dr. Fischer co-founded and co-directs UNC Project-Liberia, which was established in 2014 to provide a research response to the West African Ebola outbreak. Since then, the project has grown to include two research sites in Liberia with a staff of over 30, that serve as a clinical research platform. These include three NIAID R01-funded studies for which Dr. Fischer is PI including a longitudinal cohort study of Ebola survivors to examine long-term complications of EVD, viral persistence of Ebola virus in genital fluids, and lingering mental health issues (R01AI123535), the protective and pathologic features of the EVD survivor immune response (R01AI175698) as well as an investigation of the prevalence and incidence of Lassa fever in febrile patients admitted to Phebe Hospital in rural Liberia (R01AI135105). Dr. Fischer also served as co-PI of PREVAIL IV evaluating Remdesivir treatment in EVD survivors with seminal persistence of EBOV. Currently, Dr. Fischer serves as co-PI of a 5,000-participant community surveillance study of the incidence, seroprevalence, and natural history of Lassa fever, funded by the Coalition for Epidemic Preparedness Innovations (CEPI) that will inform future vaccine and therapeutics trials. He has weekly calls with the Liberia-based staff, separate weekly calls with the Liberia-based laboratory team, and has traveled to the research sites every quarter since 2014. Domestically, Dr. Fischer has been actively researching therapeutics for COVID-19 including as the PI for the Phase 2 study of Molnupiravir and as a co-I on ACTIV-2, is PI of a North Carolina state-funding study examining the short and long-term complications of SARS-CoV-2 infection, and Vice-Chair of the Study of Tecovirimat for Mpox (STOMP) trial sponsored by the NIH.

Awards and Honors

  • Jefferson-Pilot Fellowship Award- (2020)
  • Order of the Golden Fleece – UNC’s oldest and highest honorary society- (2019)
  • Albert Schweitzer Fellowship Leadership Award- (2019)
  • James Woods Junior Faculty Award, The University of North Carolina at Chapel Hill- (2015)
  • UNC Internal Medicine Housestaff Faculty Teaching Award- (2015)
  • UNC Internal Medicine Housestaff Faculty Teaching Award- (2014)
  • Alpha Omega Alpha, the Johns Hopkins Hospital- (2009)
  • Assistant Chief of Service, Department of Medicine, the Johns Hopkins Hospital- (2008)

In the news

  • World's-Health-Our-Health

    How Global Health Impacts Health Care in North Carolina

    Global health issues may seem geographically distant, but they directly impact our local community through travel, immigration, emerging infectious diseases, and interconnected global economies. The ‘global’ in global health refers to the scope of problems, not just their location, which can be infectious diseases with pandemic potention. UNC’s global and local engagements with resource-limited settings … Read more

  • ID-Week-2024-events

    ID Faculty Members, Fellows Present Studies During ID Week

    ID Week took place October 16-19 in Los Angeles, CA, the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. UNC’s Division of Infectious Diseases was well represented at the event. … Read more

  • BFischer-AJames-DWohl.

    IAMIGHID: Amy James Loftis

    In November 2020, Amy James Loftis was hyper-focused on keeping the Carolina community safe, building UNC’s COVID Surveillance Lab in three short months before the return of students. But there were many years leading up to that moment. Often described as the Institute’s secret weapon in the fight against global health disease, Amy travels around … Read more

  • william-fischer-mixing-tecovirimat-mpox

    William Fischer—Advancing Bedside Care During Outbreaks

    The British medical journal The Lancet profiled William Fischer, MD, associate professor of medicine and director of emerging pathogens at the UNC Institute for Global Health and Infectious Diseases, for his dedication to advancing bedside care during outbreaks. Some people have unique stories about how they met their partner, but William (Billy) Fischer’s is very … Read more

Education

  • Undergraduate

    Bates College

  • MD

    University of North Carolina School of Medicine

  • Residency

    John Hopkins Hospital

  • Fellowship

    John Hopkins Hospital